![COVID-19 tracker: Regeneron's antibody cocktail hit by safety concerns; Novo's Rybelsus emerging from pandemic slump | Fierce Pharma COVID-19 tracker: Regeneron's antibody cocktail hit by safety concerns; Novo's Rybelsus emerging from pandemic slump | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1597166780/coronavirus.jpg?VersionId=Gtjee3PxV5ivgiq4ZJYiOPh1ttUGV821)
COVID-19 tracker: Regeneron's antibody cocktail hit by safety concerns; Novo's Rybelsus emerging from pandemic slump | Fierce Pharma
![COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters | Fierce Pharma COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1619703711/GettyImages-1293456793.jpg/GettyImages-1293456793.jpg?VersionId=WB8tj9FiBVgpCnJxtaqj0TT3Gnf4tWIM)
COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters | Fierce Pharma
![E-Tech Resources Inc. Announces Final Assay Results of Phase 1 Diamond Drilling Programme from its Eureka Project in Namibia | INN E-Tech Resources Inc. Announces Final Assay Results of Phase 1 Diamond Drilling Programme from its Eureka Project in Namibia | INN](https://investingnews.com/media-library/image.jpg?id=27864874&width=1200&quality=85&coordinates=0%2C0%2C0%2C0&height=800)